# Bioequivalence Study of Didanosine in Children Treated for HIV

> **NCT00668356** · PHASE2 · SUSPENDED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 26 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** didanosine
- **DRUG:** didanosine

## Key facts

- **NCT ID:** NCT00668356
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2009-09
- **Primary completion:** 2010-09
- **Final completion:** 2010-12
- **Target enrollment:** 26 (ESTIMATED)
- **Why stopped:** questions of the benefit efficacy/risks of ddI during the meal not resolved
- **Last updated:** 2009-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00668356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00668356, "Bioequivalence Study of Didanosine in Children Treated for HIV". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00668356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*